window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biotech & Pharma Business

  • Biotech & Pharma Business,Pharmaceuticals and therapeutics,Therapeutic Areas

    Gedeon Richter UK takes over Reagila marketing and distribution rights in the UK

    Gedeon Richter UK has taken over full marketing and distribution [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Opinion & Events,Therapeutic Areas

    Wellcome awards £5.3m grant to Wysa for adolescent mental health study in India

    Wellcome has awarded £5.3m in funding to digital mental health [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Almirall secures China approval for Seysara acne treatment

    Almirall has received regulatory approval in China for its oral [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay

    Kahimmune Therapeutics has signed an exclusive licensing agreement with Gustave [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Medical devices,Therapeutic Areas

    M42’s Imperial College London Diabetes & Endocrine Centre and Medtronic to establish Middle East automated insulin delivery centre

    M42’s Imperial College London Diabetes & Endocrine Centre and Medtronic [...]

    May 5, 2026
  • Biotech & Pharma Business,Medical devices,Therapeutic Areas

    Biocomposites launches SYNICEM spacers in Canada for joint revision surgery

    Biocomposites has launched its SYNICEM antibiotic-loaded preformed spacers in Canada, [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Research finds scientists view ELNs as ‘glorified filing cabinets’, driving duplication and shadow AI use

    A new survey by Sapio Sciences has found widespread frustration [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain

    Spore.Bio appoints Michael Miller as VP of scientific and regulatory affairs

    Spore.Bio has appointed Michael Miller as vp of scientific and [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Delivery & Formulation,Medical devices

    ViCentra appoints Reman McDonagh as vice president, global marketing to support Kaleido scale-up

    ViCentra has appointed Reman McDonagh as vice president, global marketing [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    TECregen appoints Dr Klaas Zuideveld as CEO to advance thymus regeneration platform

    TECregen has appointed Dr Klaas Zuideveld as chief executive officer [...]

    May 5, 2026
Previous91011Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • William Blair highlights Carterra as key player in AI-driven drug discovery shift
    Categories: Digital & Data, Drug Discovery & Development
  • 23andMe study links genetics to GLP-1 weight loss outcomes and side effects
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Genomics and sequencing, Therapeutic Areas
  • Life Biosciences raises $80M to advance gene therapy for optic neuropathies
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top